Brief: National Institutes Of Health Awards Grant For Pivotal Clinical Trial Of gammaCore
April 26 (Reuters) - electroCore, Inc. ECOR.O :
* NATIONAL INSTITUTES OF HEALTH AWARDS GRANT FOR PIVOTAL
CLINICAL
TRIAL OF GAMMACORE™ (NVNS) IN PATIENTS WITH OPIOID USE DISORDERS
* NATIONAL INSTITUTES OF HEALTH AWARDS GRANT FOR PIVOTAL
CLINICAL
TRIAL OF GAMMACORE™ (NVNS) IN PATIENTS WITH OPIOID USE DISORDERS
Source text for Eikon: ID:nGNXbzCLXG
Further company coverage: ECOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on electroCore
See all newselectroCore, Inc. reports results for the quarter ended June 30 - Earnings Summary
electroCore Q2 revenue jumps, but slightly misses estimates
Brief: electroCore Q2 Net Income USD -3.059 Million
electroCore, Inc. expected to post a loss of 42 cents a share - Earnings Preview
electroCore reiterates FY 2026 revenue guidance